Rishi Bedi

Rishi Bedi

Company: Y-Trap

Job title: Chief Executive Officer


Overcoming Challenges of TGF-β Targeted Therapies by Selecting Suitable Combinations to Achieve Clinical Success 12:30 pm

Investigating different potential checkpoint inhibitors (SMAD, PD1) with TGF-β targetedtherapies for the most effective patient response Advancing to the next level by using proven combination TGF-β directed therapies to show clinical efficacy Employing a multi-pronged method to turn tumors from cold to hotRead more

day: Conference Day One

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.